Valid Ghana · FDA Ghana

ZABDENO SUSPENSION FOR INJECTION (EBOLA VACCINNE AD26 ZEBOV-GP [RECOMBINANT]

AD26 ZEBOV-GP [RECOMBINANT]

FDA/HVC/252-03002 AD26 ZEBOV-GP [RECOMBINANT] EACH 0.5ML DOSE CONTAINS ADENOVIRUS TYPE 26 ENCODING THE ZAIRE EBOLA VIRUS (EBOV) MAYINGA VARIANT GLYCOPROTEIN (GP) NOT LESS THAN 8.75LOG10 INFECTIOUS UNITS

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/HVC/252-03002
Registration date
2026-01-24
Expiry date
2027-04-01
Status
Valid
Active ingredient
AD26 ZEBOV-GP [RECOMBINANT]
Dosage form
AD26 ZEBOV-GP [RECOMBINANT]
Strength
EACH 0.5ML DOSE CONTAINS ADENOVIRUS TYPE 26 ENCODING THE ZAIRE EBOLA VIRUS (EBOV) MAYINGA VARIANT GLYCOPROTEIN (GP) NOT LESS THAN 8.75LOG10 INFECTIOUS UNITS
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Janssen-Cilag
Applicant / LTR
JOHNSON AND JOHNSON MIDDLE EAST FZLLC GHANA BRANCH, 3RD FLOOR NESTER SQUARE AIRPORT CITY, ACCRA
Country of origin
BELGIUM
Manufacturer location
Antwerpseweg 15, 2340 Beerse, Belgium

Source: Food and Drugs Authority · fetched 2026-04-18 08:37:20 · updated 2026-10-30 04:00:10

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.